ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Oct 13, 2016
Insider Transaction Report
Form 4
Pharmstandard International S.A.
10% Owner
Transactions
- Purchase
Common Stock
2016-10-05$4.85/sh+900$4,365→ 13,218,639 total(indirect: See footnote) - Purchase
Common Stock
2016-10-07$4.73/sh+21,000$99,330→ 13,242,279 total(indirect: See footnote) - Purchase
Common Stock
2016-10-06$4.81/sh+2,640$12,698→ 13,221,279 total(indirect: See footnote) - Purchase
Common Stock
2016-10-04$4.69/sh+7,164$33,599→ 13,217,739 total(indirect: See footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.80 to $4.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $4.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.